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Global Resistance Hot Spots - Role of low and
middle income countries
U. Theuretzbacher
CEFAIA, Vienna, Austria
Bacterial resistance is undoubtedly recognised as a major med-
ical challenge in most healthcare systems. Resistance-determining
genes,mostly in combination, andextensivelydrug-resistant (XDR)
pathogens are spreading with unprecedented speed. Low- and
middle-income countries with limited economic resources, high
disparity in standard of living, weak national drug regulatory
authorities, inefﬁcient antibiotic policies, and erratic access to
antibiotics are important high-impact resistance regions which
contribute signiﬁcantly to the global pool of resistance genes and
difﬁcult-to-treat-infections. Emergingmarkets, suchasChina, India
and Brazil will face a growing resistance selection pressure while
antibiotics become commodities in insufﬁciently regulated mar-
kets. The escalating resistance crisis will have a great impact on
all civil societies worldwide. In high-income countries, empirically
used ineffective antibiotics in the case of XDR or pandrug-resistant
infections in critically ill patients will result in high mortality. In
low- and middle-income countries, multidrug resistance leads to
untreatable resistant infectionsmuch earlier in the escalating chain
of resistant events as they do not have a broad enough selection of
second-line drugs, and novel antibiotics may not be available or
affordable. Moreover, the weak political will to face this problem
and take concerted action inmany resistance hot spots of theworld
accelerates the resistance spiral and puts all other countries, espe-
cially thosewith low resistance rates, at risk for increased imported
resistance. This gloomy scenario of resistance with limited or no
treatment option is already seen in some parts of the world and
will inﬂuence the life expectancy as it threatens the advances of
modern medicine.
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Factors driving antimicrobial resistance in low-
and middle-income countries
R. Laxminarayan
Public Health Foundation of India, New Delhi, India
Antimicrobial use is increasing, particularly in Asian and Latin
American countries where rising incomes are enabling greater
access. The delicate balance in developing countries is between
encouraging greater use for appropriate indications—consider the
one million deaths of children each year from pneumonia, much
of it untreated—and the overwhelming tendency for inappropri-
ate use of antimicrobials. In this talk, we cover recent trends in
antibiotic consumption in low-and middle-income countries and
the factors responsible for these changes and their potential impact
on antimicrobial resistance.
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Bridging the infection prevention and control
(IPC) gap between theory and implementation -
An African experience
S. Mehtar
Stellenbosch University, Stellenbosch, South Africa
The burden of healthcare associated disease in Africa is up to
twenty times higher than high income countries. South Africa is
fortunate inhaving strong support fromtheNationalDepartmentof
Health which is not necessarily the case in other African countries.
There may be several reasons for this; 1) IPC is very much in its
infancy inAfrica andcurrently is being spearheadedby the Infection
Control Africa Network (ICAN); 2) it is considered there are other
more urgent health priorities than IPC; 3) the IPC education and
skills development systems that exist in the high income countries
do not always apply in low technology or rural environments. It is
therefore essential that within the principles of IPC, practice and
implementation is applicable to African healthcare systems with
low resources- much can be done with good education.
The Unit for IPC, Stellenbosch University has developed a sim-
ple yet robust, training programme in IPC. The IPC course is tailor
made to ensure that themajor gaps found in the pre assessment are
covered with practical examples in the clinical arena; a Certiﬁcate
of Competence is issued. This basic IPC course is being developed
into distance learning as well as tele-classes in several African lan-
guages.
There are also speciﬁc courses for IPC practitioners such as the
six-month Fundamental IPC Course, and a two year part-time Post
graduate Diploma; Masters in IPC has been introduced since 2013.
Sterile Service training is as short courses and aDiploma inHospital
Technology is being developed in collaborationwith the University
of Namibia. Finally, there is an education project known as Cape to
Cairo education programme being developed based on SMS/Text
messaging systems using mobile phones to educate both civil soci-
ety as well as remotely placed healthcare workers across Africa.
The impact of these education programmes is continuously
assessed by an independent accreditation body and improvements
have been signiﬁcant.
http://dx.doi.org/10.1016/j.ijid.2014.03.528
